Data Show that Sales in the Legal Cannabis Market set to Expand

Tuesday, March 6, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, March 6, 2018 /PRNewswire/ --

According to data provided

by Ameri Research Inc., the global legal cannabis market is forecast to be valued at $63.5 billion by 2024, and growing at a CAGR of 21.1% between 2017 to 2024. Currently, the market is going through a period of robust growth
thanks to increasing legalization and decriminalization of cannabis products across North America and Europe. In the U.S, there are 28 states which have approved the use of cannabis for medical purposes. In major markets like Colorado, California, Alaska, Massachusetts and Nevada, cannabis is legal for recreational use. Global Payout, Inc. (OTC: GOHE), GrowLife, Inc. (OTC: PHOT), GB Sciences, Inc. (OTC: GBLX), Cannabis Science, Inc. (OTC: CBIS), American Cannabis Company, Inc. (OTC: AMMJ)

Data shows positive developments for the legal cannabis market across North America and Europe. Tom Adams, Editor-in-Chief at Arcview Market Research and Principal Analyst at BDS Analytics explained, "Our data shows positive indicators across the board for the legal cannabis industry, in North America and around the globe. The passage of the 2016 ballot initiatives and continued maturation of the existing Adult-Use markets are the primary drivers of the growth this year. That's nothing compared to what we can expect in 2018 and beyond from Nevada's tourism, and California and Canada planning to launch Adult-Use sales in 2018."

Global Payout, Inc. (OTC: GOHE) last week announced breaking news, "Its PotSaver brand has expanded its advertising net to include businesses outside of cannabis throughout the communities it serves with the intent of delivering more value to its growing base of patrons and subscribers. To support this expansion, PotSaver is currently engaged in the process of expanding its salesforce to more effectively explore the many different market sectors and ancillary services that can be tied into their publication.

A Cannabis Marketplace Report published by Consumer Research Around Cannabis has reported that there are about 13.7 million adults over the age of 21 in the Los Angeles Greater Metropolitan Area and approximately 5.3 million of those people are cannabis consumers. According to Ackrell Capital, California's legal medical marijuana industry has already topped $3.8 billion, and with the flourishing of new ancillary services in legal support, marketing, business development and many others, it is pushing a massive demand for employees in order to meet the demands of a rapidly expanding consumer marketplace."

Said MTRAC CEO, Vanessa Luna: "PotSaver was initially established to connect consumers throughout the cannabis industry with value-driven deals on the many different products they purchase for both recreational and medicinal purposes. However, as the industry has morphed into the multi-billion-dollar industry it is today, we recognize that this is now, more than ever, a community made up of your everyday consumers who are looking for more than just deals on cannabis products, but who are also eager to find deals on other products and services that are offered by the many different businesses in their local communities, and we are committed to developing PotSaver into a resource they can rely on for all of this."

GrowLife, Inc. (OTC: PHOT) aims to become the nation's largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. On February 6, 2018, the company announced that GrowLife HP Soil, the Company's organic certified high-porosity peat mix, was tested and selected for exclusive use in three major indoor cultivation sites across the country, including in one of the nation's largest state-sanctioned cultivation facilities with over 120,000 square feet of production room in Colorado. Denver, Colorado-based Green Man Cannabis, a Colorado cannabis cultivation and dispensary chain, ran a multiple-month test with GrowLife HP that delivered such favorable results that the company has entered into an agreement to exclusively use GrowLIfe's highly oxygenated soil for all further production in the facility. In addition to their operations in Colorado, Green Man has begun using GrowLife HP in its cannabis cultivation facilities in Portland, Oregon, under the brand Phresh and in Las Vegas, Nevada, under the brand Greenway Medical. GrowLife recently announced the opening of a flagship Canadian retail location built in order to meet the growing market demand for indoor cultivation equipment in the emerging legal cannabis Canadian marketplace.

GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. Last month, the company announced it has been issued its production license and now begins full production operations in the Las Vegas, Nevada facility. Production license partners include Relax With Happy™ ("RWH"), a new venture co-founded by veteran cannabis chef, Deliciously Dee™, and Cura Cannabis Solutions, maker of the best-selling cannabis brand on the West Coast, Select Oil. Given already announced contractual arrangements with those production partners, operations are expected to generate significant monthly free cash flow after a ramp up period of approximately two months.

Cannabis Science, Inc. (OTC: CBIS) is a U.S. company specializing in the development of cannabinoid-based medicines. On February 2, 2018, the company has entered into an expanded 5-year, $1.8 million Research Collaboration Agreement with Dana Farber Cancer Institute, Inc., encompassing operating procedures and related communication activities. The work will be focused on essentially the same clinical targets with expanded work parameters based on current laboratory success. Cannabis Science's current laboratory research forms part of an aggressive drug development pipeline targeting critical ailments from laboratory research to scientific publication that Cannabis Science is developing with its research partners. This strongly demonstrates and effects the Company's strong commitment to cutting-edge cannabinoid science in its pharmaceutical development programs. Cannabis Science has developed this pipeline to ensure that the Company's research work reaches the scientific community and the patients in a timely fashion.

American Cannabis Company, Inc. (OTCQB: AMMJ) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. Earlier this year, the company announced that it has secured a consulting contract with Cloud 9 Apothecary in the state of California. In conjunction with the consulting agreement, ACC will acquire an equity stake in Cloud 9's project that is currently non-operational and in the development stage. This project, to be built-out and completed in Desert Springs, California, will comprise a closed-loop greenhouse containing a 22,000 square foot canopy of premium cannabis cultivars. With the construction of this facility, Cloud 9 Apothecary's plans focus on wholesale cultivation and product manufacturing. Plans to shift into a fully integrated business model, complete with dispensing solutions, will be made in the near future as Cloud 9 plans to scale up operations organically.

Subscribe Now! Watch us report LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For global payout, inc. financial news dissemination and PR services, has been compensated four thousand dollars for financial news dissemination and PR services by cambridge consultants. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit:

For further information: +1-877-601-1879



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store